Regarding the route of administration, perhaps nebulization for direct delivery to the lungs may maximally target the infection and regeneration pathways discussed herein, while systemic delivery might have a more far-reaching effect to inhibit the NOTCH : IL-6 positive feedback loop in immune cells, and might also be predicted to cause more on-target, off-disease side-effects. Here, IL6 is linked to infection.